Evidence map›Paper›PMID 23775149›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2014

PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.

A C Vidal, N M Henry, S K Murphy, O Oneko, M Nye, J A Bartlett, F Overcash, Z Huang, F Wang, P Mlay and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Long intergenic noncoding RNA LINC00284 knockdown reduces angiogenesis in ovarian cancer cellsFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  10. Article
  11. Article
  12. Stressful Newborn Memories: Pre-Conceptual,Frontiers in psychiatry · 2019
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

A C VidalDepartment of Obstetrics and Gynecology, Program of Cancer Detection, Prevention and Control, Duke University School of Medicine, P.O. Box 104006, Durham, NC, 27710, USA, adriana.vidal@duke.edu.
N M Henry
S K Murphy
O Oneko
M Nye
J A Bartlett
F Overcash
Z Huang
F Wang
P Mlay
J Obure
J Smith
B Vasquez
B Swai
B Hernandez
C Hoyo
Duke University · USKilimanjaro Christian Medical Centre · TZTumaini University · TZDuke Medical Center · USUniversity of Hawaiʻi at Mānoa · USUniversity of North Carolina at Chapel Hill · US

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
LINEBERGER CANCER CONTROL EDUCATION PROGRAMR25CA057726 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI EARP, JO ANNE L, RIBISL, KURT M. · 1992 to 2016
$8.0M
Disparities in cervical cancer precursors and deregulation of imprinted genesR01CA142983 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI HOYO, CATHRINE, MURPHY, SUSAN KAY · 2010 to 2014
$3.0M
Insulin-like Growth Factors and Esophageal CancerK01CA104517 · NCI · DUKE UNIVERSITY · PI HOYO, CATHRINE · 2004 to 2008
$671k
NCI NIH HHS K01 CA104517NCI NIH HHS R01 CA142983NCI NIH HHS R01CA142983NCI NIH HHS R01CA142983-02S1NCI NIH HHS R25 CA057726NIAID NIH HHS 5P30 AI 064518NIAID NIH HHS P30 AI064518
6 · The paper itself

Abstract

introductionAlthough most invasive cervical cancer (ICC) harbor <20 human papillomavirus (HPV) genotypes, use of HPV screening to predict ICC from HPV has low specificity, resulting in multiple and costly follow-up visits and overtreatment. We examined DNA methylation at regulatory regions of imprinted genes in relation to ICC and its precursor lesions to determine if methylation profiles are associated with progression of HPV-positive lesions to ICC. MATERIALS AND

methodsWe enrolled 148 controls, 38 CIN and 48 ICC cases at Kilimanjaro Christian Medical Centre from 2008 to 2009. HPV was genotyped by linear array and HIV-1 serostatus was tested by two rapid HIV tests. DNA methylation was measured by bisulfite pyrosequencing at regions regulating eight imprinted domains. Logistic regression models were used to estimate odd ratios.

resultsAfter adjusting for age, HPV infection, parity, hormonal contraceptive use, and HIV-1 serostatus, a 10 % decrease in methylation levels at an intragenic region of IGF2 was associated with higher risk of ICC (OR 2.00, 95 % CI 1.14-3.44) and cervical intraepithelial neoplasia (CIN) (OR 1.51, 95 % CI 1.00-2.50). Methylation levels at the H19 DMR and PEG1/MEST were also associated with ICC risk (OR 1.51, 95 % CI 0.90-2.53, and OR 1.44, 95 % CI 0.90-2.35, respectively). Restricting analyses to women >30 years further strengthened these associations.

conclusionsWhile the small sample size limits inference, these findings show that altered DNA methylation at imprinted domains including IGF2/H19 and PEG1/MEST may mediate the association between HPV and ICC risk.

Indexed as

DNA MethylationAdultFemaleHumansInsulin-Like Growth Factor IIMiddle AgedPapillomavirus InfectionsProteinsUterine Cervical DysplasiaUterine Cervical NeoplasmsIGF2 protein, humanInsulin-Like Growth Factor IImesoderm specific transcript proteinProteins

Identifiers

PMID23775149
PMCPMC3924020
OpenAlexW2085769697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.